Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
Huntington's disease (HD) is a progressive neurodegenerative disorder for which, until now, only symptomatic treatment has been available. Lately, there have been multiple ongoing clinical trials targeting therapeutic agents for preventing disease onset or slowing disease progression in HD. These st...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2025-01-01
|
| Σειρά: | Neurology International |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/2035-8377/17/1/13 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|